Skip to main content

PVCT

Provectus Biopharmaceuticals, Inc.

Company with tickers: PVCT

CIK
315545
CUSIP
74373P108
Shares Outstanding
420,279,879
13F Activity (30d)
3 filings 3 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 6
Total Value: $10,321
Total Shares: 202,412

Institutional Ownership Trend

24 quarters

Holder Concentration

Across 6 13F filers · Δ vs Dec 31, 2025
Top Holder
49.4%
Sep 2023 → Mar 2026 · range 43.6% – 56.6%
−5.3 pts
Top 5
100.0%
Sep 2023 → Mar 2026 · range 95.5% – 100.0%
0.0 pts
Top 10
100.0%
Sep 2023 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
3,334
Sep 2023 → Mar 2026 · range 2,712 – 3,972
Highly concentrated−639

Quarterly Activity

vs Dec 31, 2025
New
1
Increased
0
Decreased
0
Sold Out
0
Unchanged
5
Holder count: +1
Institutional value: +0.8%
Shares held: +10.7%

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
No fully closed positions this quarter.
Showing 6 of 6
Export CSV
Holder Value (USD) % of 13F Shares Open